These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 29076065)
21. Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii. Htoo HH; Brumage L; Chaikeeratisak V; Tsunemoto H; Sugie J; Tribuddharat C; Pogliano J; Nonejuie P Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745382 [TBL] [Abstract][Full Text] [Related]
22. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
24. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730 [TBL] [Abstract][Full Text] [Related]
25. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784 [TBL] [Abstract][Full Text] [Related]
26. Genomic sequencing of a strain of Acinetobacter baumannii and potential mechanisms to antibiotics resistance. Zhao L; Li H; Zhu Z; Wakefield MR; Fang Y; Ye Y Infect Genet Evol; 2017 Jun; 50():20-24. PubMed ID: 28189888 [TBL] [Abstract][Full Text] [Related]
27. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development. Saipriya K; Swathi CH; Ratnakar KS; Sritharan V J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552 [TBL] [Abstract][Full Text] [Related]
28. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406 [TBL] [Abstract][Full Text] [Related]
29. Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter. Godeux AS; Svedholm E; Barreto S; Potron A; Venner S; Charpentier X; Laaberki MH mBio; 2022 Feb; 13(1):e0263121. PubMed ID: 35073754 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. Biglari S; Hanafiah A; Mohd Puzi S; Ramli R; Rahman M; Lopes BS Microb Drug Resist; 2017 Jul; 23(5):545-555. PubMed ID: 27854165 [TBL] [Abstract][Full Text] [Related]
32. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii. Minrovic BM; Jung D; Melander RJ; Melander C ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069 [TBL] [Abstract][Full Text] [Related]
33. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii. Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752 [TBL] [Abstract][Full Text] [Related]
34. [Epidemiology and clinical features of Acinetobacter baumannii infections in humans]. Wisplinghoff H; Seifert H Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):447-57. PubMed ID: 25872254 [TBL] [Abstract][Full Text] [Related]
35. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Alharbe R; Almansour A; Kwon DH Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060 [TBL] [Abstract][Full Text] [Related]
36. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182 [TBL] [Abstract][Full Text] [Related]
37. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Durante-Mangoni E; Zarrilli R Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942 [TBL] [Abstract][Full Text] [Related]
38. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance. Lin MF; Lin YY; Tu CC; Lan CY J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
40. New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii. Smani Y; Pachón-Ibáñez ME; Pachón J Expert Opin Pharmacother; 2016 Jun; 17(9):1207-14. PubMed ID: 27067283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]